Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Clinical trial NCT00050817 · COMPLETED

Trial details

NCT number: NCT00050817
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arteriosclerosis

Start date: 2002-10-01
Enrollment: 15603

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.